Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis associated with connective tissue disorders

P A Bacon1, D M Carruthers

  • 1Department of Rheumatology, Faculty of Medicine/Dentistry, University of Birmingham, United Kingdom.

Rheumatic Diseases Clinics of North America
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Arthritis and rheumatism·2012
Same author

The Use of Quantitative Thermography to Assess the Anti-inflammatory Dose Range for Fenclofenac.

Proceedings of the Royal Society of Medicine·2010
Same author

Intracellular calcium signalling patterns reflect the differentiation status of human T cells.

Clinical and experimental immunology·2008
Same author

Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists.

Rheumatology (Oxford, England)·2007
Same author

Impaired endothelial function in systemic lupus erythematosus.

Lupus·2007
Same author

Development of an interactive learning tool for teaching rheumatology--a simulated clinical case studies program.

Rheumatology (Oxford, England)·2006
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Vasculitis associated with connective tissue diseases involves distinct immunopathologic mechanisms. Differentiating true vasculitis from vasculopathy is crucial for appropriate treatment, guiding therapy towards immunosuppression or anticoagulation.

Area of Science:

  • Rheumatology
  • Immunology
  • Pathology

Background:

  • Vasculitis frequently co-occurs with connective tissue diseases.
  • Secondary vasculitides share histological similarities with primary forms but have different immunopathologic mechanisms.
  • Vessel size and clinical manifestations vary widely depending on the underlying connective tissue disease.

Purpose of the Study:

  • To explore the association between vasculitis and connective tissue diseases.
  • To differentiate the immunopathologic mechanisms of secondary vasculitides from primary systemic necrotizing vasculitis.
  • To highlight the clinical diversity and diagnostic challenges in vasculitis secondary to connective tissue diseases.

Main Methods:

  • Review of immunopathologic mechanisms.

Related Experiment Videos

  • Histological comparison of vasculitic lesions.
  • Analysis of clinical manifestations across different connective tissue diseases.
  • Distinguishing vasculitis from vasculopathy.

    • Main Results:

    • Immunopathologic pathways, including complement and immune-complex involvement, differ between secondary and primary vasculitides.
    • Histological identity of lesions does not preclude different underlying mechanisms.
    • Clinical presentations are diverse and disease-specific.
    • Small vessel biopsy findings do not rule out larger vessel involvement.

    Conclusions:

    • Accurate distinction between vasculitis and vasculopathy is essential for effective management.
    • Treatment strategies (immunosuppression vs. anticoagulation) depend critically on identifying underlying inflammation.
    • Understanding the specific immunopathogenesis in connective tissue disease-associated vasculitis informs therapeutic decisions.